IA-WORKIVA
20.10.2021 14:02:05 CEST | Business Wire | Press release
Workiva Inc. (NYSE:WK), the company that simplifies complex work, announced the winners of the 2021 Workiva Partner of the Year Awards. The awards recognize partners that have leveraged their significant industry and solution-specific experience to help customers expand their use of the Workiva platform to drive transparency in reporting and compliance. Award recipients were recognized during the Company’s virtual Global Partner Summit , held October 18 & 19.
“Our partners are instrumental in deploying the Workiva platform as a critical component in digital transformations across global enterprises,” said Corey Wells, vice president of partnerships and alliances at Workiva. “It’s an honor to recognize this year’s winners for helping drive the innovation and collaboration that has made a lasting impact on our customers' business.”
2021 Partner of the Year Award Winners
- Global Partner of the Year - Deloitte
- Global Technology Partner of the Year - FloQast
- North American Advisory Partner of the Year - PwC US
- North American Mid-Market Advisory Partner of the Year - Clearview Group
- North American Emerging Partner of the Year - DHG
- EMEA Partner of the Year - PwC Germany
- EMEA Emerging Partner of the Year - Advance Tax Compliance
- APAC Partner of the Year - PwC Hong Kong , PwC Japan , and PwC Taiwan
- Partner Innovation Award Winner - F.H. Black
More about the 2021 Partner of the Year Award Winners
Advance Tax Compliance (ATC) delivers high-quality implementations and supports the Workiva sales team with new clients. ATC is also an active contributor to Workiva marketing events, client demos and the Workiva Marketplace.
Clearview Group * has been named the North American Mid-Market Advisory Partner of the Year two years in a row. Clearview Group has a masterful understanding of Workiva solutions and delivers a compelling value story. Clearview Group has grown with Workiva, from supporting integrated risk management to developing a comprehensive service line, delivering advisory and transformation services powered by collaboration across management reporting, and financial reporting as well.
Deloitte * has been named global partner of the year two years in a row. Deloitte collaborates globally with Workiva, introducing the company to new customers, identifying new use cases and supporting sales teams. Deloitte has been instrumental in communicating the value of the Workiva platform and helping global customers use innovative technology to help address complex business problems.
DHG , a top 20 public accounting, tax, and advisory firm, helped bring Workiva’s Global Statutory Reporting (GSR) and Environmental, Social, and Governance (ESG) offerings to market. DHG’s global teams work across EMEA and North America with Workiva to help joint customers, which include some of the largest companies in the world, navigate the complexities of GSR and ESG reporting.
F.H. Black * is a groundbreaking services partner that has elevated and extended the most technically advanced aspects of the Workiva platform. F.H. Black's innovative methodology and investment into collaborating with the Workiva product teams have helped tailor Workiva’s solutions for the public sector, specifically the development of Government Finance Officers Association (GFOA) compliant financial reports, budget books, Governmental Accounting Standards Board (GASB) 87 solutions and State-mandated solutions.
FloQast * has won the Global Technology Partner of the Year award two years in a row. FloQast continues to bring extreme value to Workiva and their joint customers with their accounting workflow automation solution. FloQast also invested in developing a direct API into the Workiva platform to provide joint customers increased visibility of the Close to Report process that spans the Finance, Accounting and Reporting teams.
PwC* has a dedicated alliance team with a depth of experience that helps strengthen Workiva's global position as a strategic platform for businesses. PwC collaborates with Workiva globally across all use cases and seeks opportunities to embed Workiva into PwC tech-enabled offerings. PwC continually invests and grows their Workiva-focused resources and is dedicated to accelerating the success of Workiva and their shared, global customers. PwC was recognized for three regional awards: North American Partner of the Year (PwC US), EMEA Partner of the Year (PwC Germany), and APAC Partner of the Year (PwC Hong Kong, PwC Japan, and PwC Taiwan).
*Denotes Workiva Marketplace Innovator. Marketplace Innovators played a crucial role in the launch of the Workiva Marketplace by contributing meaningful templates, services and content that were readily available for customers to add to their workspaces and use upon the launch of the marketplace in August, 2021.
About Workiva
Workiva Inc. (NYSE: WK) simplifies complex work for thousands of organizations worldwide. Customers trust Workiva’s open, intelligent and intuitive platform to connect data, documents and teams. The results: improved efficiency, greater transparency and less risk. Learn more at workiva.com .
Read the Workiva blog: www.workiva.com/blog
Follow Workiva on LinkedIn: www.linkedin.com/company/workiva
Like Workiva on Facebook: www.facebook.com/workiva/
Follow Workiva on Twitter: www.twitter.com/Workiva
Follow Workiva on Instagram: www.instagram.com/workivalife
View source version on businesswire.com: https://www.businesswire.com/news/home/20211020005117/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release
Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
Half-Year Report on SES’s Liquidity Contract31.7.2026 07:30:00 CEST | Press release
Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th
SES Publishes FY2025 EU Taxonomy Restatement31.7.2026 07:30:00 CEST | Press release
SES today published a restatement of its FY2025 EU Taxonomy (Article 8) disclosure. The restatement updates the FY2025 EU Taxonomy disclosure included in the 2025 Annual Report and supersedes the previously published disclosure. The FY2025 EU Taxonomy Restatement is available on the SES website: https://www.ses.com/sites/ses_v2/files/investor-files/2026-07/EU_Taxonomy_Report_Restatement_2025.pdf Follow us on: X | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where they are. With integrated multi-orbit satellites and our global terrestrial network, we deliver resilient, seamless connectivity and the highest quality video content to those shaping what’s next. Following our Intelsat acquisition, we now offer more than 100 years of combined global industry l
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom